RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Long-term debt, non-current

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Period EndLong-term debt, non-current (Million USD)YoY (%)
Dec 31, 202412,625-7.16%
Dec 31, 202313,599-6.36%
Dec 31, 202214,522-16.04%
Dec 31, 202117,296-6.64%
Dec 31, 202018,527+11.20%
Dec 31, 201916,661-13.94%
Dec 31, 201819,359-28.85%
Dec 31, 201727,210+31.57%
Dec 31, 201620,681+252.26%
Dec 31, 20155,871+72.27%
Dec 31, 20143,408+0.59%
Dec 31, 20133,388-81.27%
Dec 31, 201218,085+50.21%
Dec 31, 201112,040-3.86%
Dec 31, 201012,524

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)